Earnings Call Excerpt
Teva Pharmaceutical Industries, (TEVA)
Q2 2006 Earnings Conference Call
August 8, 2006, 8:45 a.m. EST
Executives:
Israel Makov, President and Chief Executive Officer
Moshe Manor, Group vice President, Global Innovative Resources
Dan Suesskind, CFO
William Marth, President & CEO, Teva Pharmaceuticals USA
George Barrett, Group VP, North America, President & CEO, North America
Kevin Mannick, Director Investor Relations
Analysts:
Robert Bonte-Friedheim, Citigroup
Rick Silver, Lehman Brothers
David Woodburne, Prudential Equity Group
Elliott Wilbur, CIBC World Markets
Andrew Foreman, W.R. Hambrandt
Ron Miguel, Sanford Bernstein
Greg Gilbert, Merrill Lynch
Norman Fidel, Alliance Capital
Ken Cacciatore, Cowen & Co
Randall Fenicki, Goldman Sachs
David Buck, Buckingham Research
Presentation
Operator
Greetings ladies and gentlemen and welcome to the Teva Pharmaceutical Industries Ltd. Second Quarter 2006 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press * and 0 on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Kevin Mannick, North American Director of Investor Relations of Teva Pharmaceuticals Industries. Thank you, you may begin Mr. Mannick.
Kevin Mannick, Director Investor Relations
Thanks a lot Dan. Good morning and good afternoon everyone. Welcome to Teva’s Second Quarter 2006 Earnings Conference Call. We hope you’ve all had a chance to review our press release which we issued earlier this morning. A copy of the press release is available on our website at www.tevapharm.com. Additionally, we are conducting a live webcast of this call which is also available on our website. Today, we are joined by Israel Mackoff, President and CEO; Dan Suesskind, Chief Financial Officer; George Barrett, President and CEO of Teva North America; Bill Marth, President & CEO of Teva USA; and Moshe Manor, Vice President, Global Innovative Resources. Israel, George, and Dan will begin by providing an overview of our results. We will then open up the call for a question and answer period.
I’d also like to remind all of you that we will host a special quarterly luncheon tomorrow in New York. For those of you who haven’t received our invitation or have not RSVP’d yet, please call 215-591-8726, and if you’re unable to join us we are conducting a live webcast of the event, which will also be available on our website.
- To read the full transcript on Seeking Alpha, click here »
